Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic Diseases
NCT06786754 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2025-09-10
Summary
The aim of the present study is to characterise the phenotype of fibroblasts and to classify different mechanisms involved in the onset and progression of TAAD in syndromic and non-syndromic subjects in order to evaluate potential markers related to TAAD.
Conditions
- Rare Diseases
- Thoracic Aortic Aneurysm (TAA)
- Marfan Syndrome
Sponsors & Collaborators
-
University of Milan
collaborator OTHER -
IRCCS Policlinico S. Donato
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-06-17
- Primary Completion
- 2025-12-31
- Completion
- 2026-02-28
Countries
- Italy
Study Locations
More Related Trials
-
Defining the Basis of Fibromuscular Dysplasia (FMD)
NCT01967511 ·Status: RECRUITING
-
Prevalence and Characterization of Pain in RASopathies
NCT06355622 ·Status: RECRUITING ·Phase: NA
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients
NCT03558854 ·Status: COMPLETED ·Phase: PHASE4
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
NCT00418132 ·Status: TERMINATED ·Phase: PHASE1
-
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
NCT01387035 ·Status: RECRUITING
-
Gene First Approach to Connective Tissue Disease
NCT04664478 ·Status: COMPLETED
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Collagenase in the Treatment of Dupuytrens Disease
NCT00260429 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Screening Strategies for Scleroderma PAH
NCT01959815 ·Status: COMPLETED
-
microRNAs in Systemic Scleroderma
NCT04148716 ·Status: COMPLETED
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
NCT03211325 ·Status: COMPLETED ·Phase: NA
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
NCT02165111 ·Status: COMPLETED ·Phase: PHASE3
-
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
NCT01829126 ·Status: UNKNOWN
-
Calcinosis in a Single-Center Scleroderma Population
NCT02062125 ·Status: COMPLETED
-
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
NCT07183072 ·Status: RECRUITING
-
Effects of FT011 in Systemic Sclerosis
NCT04647890 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT06177353 ·Status: RECRUITING
-
High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
NCT00428883 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT02810951 ·Status: TERMINATED ·Phase: PHASE1/PHASE2